Experimental treatments for type 2 diabetes include stem cell therapy, endoscopic re-cellularization via electroporation therapy (ReCET), and combination drug therapies. These experimental therapies ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...

At present, around 59 million adults worldwide have diabetes, about 64 million are diagnosed with heart failure, and ...

Groundbreaking research presented at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that could significantly reduce or even eliminate the need for insulin therapy.

86% of type 2 diabetes patients treated with a new procedure no longer needed insulin throughout the two-year-long study they participated in. That procedure could be a real game changer for nearly ...

Type 2 diabetes care has entered a smarter, more personal era — where technology, medicine, and lifestyle all work together. Continuous glucose monitors now give people real-time feedback on how meals ...

One very successful drug for type 2 diabetes management is semaglutide. It works as a glucagon-like peptide 1 (GLP-1) agonist, stimulating insulin release and reducing glucagon secretion, which leads ...

Over the past few decades, doctors have noticed a sharp increase in type 2 diabetes among Black children and teenagers. Since type 2 diabetes is showing up earlier in life, it is leading to more ...

Type 2 diabetes can decrease saliva production and increase glucose levels in saliva. This may lead to plaque and tartar buildup on teeth and gums, increasing the chances of developing gum disease.

ST. PAUL, Minn., Nov. 6 (UPI) --Positive results from a late-stage clinical trial released Thursday have raised hopes that type 1 diabetes patients who suffer from chronic kidney disease will have a ...